© Reuters Will Ruihui’s light fade when the epidemic subsides?
Investing.com – Pfizer (NYSE: ) CEO Albert Bourla reiterated Pfizer’s post-epidemic strategy during an investment conference on Monday (9).
After the meeting, Credit Suisse analysts told investors in a report that Pfizer would focus on non-new crown assets.
Analysts expect sales of Pfizer’s non-new crown business to grow 6% from 2020 to 2025 and 6% to 10% from 2025 to 2030. Credit Suisse’s forecast was better than the market consensus and has assigned Pfizer an outperform rating and a $55 price target.
Credit Suisse also said the new corona business is still an important source of revenue for Pfizer. As the price of new corona-related products returns to commercialization, sales are expected to continue to grow after 2023 and combined flu/new crown products also become more and more popular. .
However, analysts at JP Morgan gave Pfizer a neutral rating, noting that with “Pfizer spending also expected to rise in 2023, it’s no surprise that the stock price is consolidating as Wall Street seeks to learn more about the dynamics.” of short-term sales/profits. of core businesses and COVID-19.” .”
“At the same time, we believe that Pfizer’s business development initiatives in 2022 are moving in the right direction and that the market has a clearer understanding of the company’s long-term growth prospects and further progress on these aspects could be the welcome”.
In addition, Goldman Sachs analysts believe Pfizer could make more acquisitions than in 2022 during the ten-year period ending in 2030, targeting biotech companies to meet a $25 billion business development goal.
Analysts also said Pfizer has a richer product line in research and greater flexibility in allocating capital, giving the company significant choice. Goldman Sachs also believes Pfizer can perform well even if the epidemic is underestimated.
[ThisarticleisfromInvestingasyoucanaccessittofindoutmore[QuestoarticoloèdiInvestingcomaccedipersapernedipiùcn.investing.comor downloadYingwei Caiqing application】
to adviseto read
Compiler: Liu Chuan
